Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schwannomatosis”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableUnknownNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableLooking for participantsNCT01885767
What this trial is testing

Neurofibromatosis (NF) Registry Portal

Who this might be right for
Neurofibromatosis 1Neurofibromatosis 2Schwannomatosis
The Children's Tumor Foundation 20,000
Testing effectiveness (Phase 2)UnknownNCT04163419
What this trial is testing

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Who this might be right for
SchwannomatosisPain
Massachusetts General Hospital 9
Not applicableStudy completedNCT02435628
What this trial is testing

Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF

Who this might be right for
Neurofibromatosis
Massachusetts General Hospital 86
Testing effectiveness (Phase 2)UnknownNCT04085159
What this trial is testing

Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis

Who this might be right for
Cancer
Shenzhen Geno-Immune Medical Institute 100
Not applicableStudy completedNCT02298270
What this trial is testing

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Who this might be right for
NeurofibromatosisNeurofibromatosis INeurofibromatosis 2+1 more
Massachusetts General Hospital 65
Post-approval studies (Phase 4)WithdrawnNCT00588172
What this trial is testing

Genetic Variation in OCT1 and Response to Metformin

Who this might be right for
Type 2 Diabetes
Mayo Clinic
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Not applicableLooking for participantsNCT07420751
What this trial is testing

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Who this might be right for
NF2-related Schwannomatosis
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04374305
What this trial is testing

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+2 more
Scott R. Plotkin, MD, PhD 100
Testing effectiveness (Phase 2)Looking for participantsNCT05684692
What this trial is testing

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Who this might be right for
SchwannomatosisSchwannomasPain, Chronic
Massachusetts General Hospital 40
Not applicableStudy completedNCT03406208
What this trial is testing

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Who this might be right for
NeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2+1 more
Massachusetts General Hospital 228